Correlation Between Harvia Oyj and Herantis Pharma

Can any of the company-specific risk be diversified away by investing in both Harvia Oyj and Herantis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Harvia Oyj and Herantis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Harvia Oyj and Herantis Pharma Oyj, you can compare the effects of market volatilities on Harvia Oyj and Herantis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Harvia Oyj with a short position of Herantis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Harvia Oyj and Herantis Pharma.

Diversification Opportunities for Harvia Oyj and Herantis Pharma

-0.11

Correlation Coefficient

Harvia Oyj  Herantis Pharma

Good diversification

The 3 months correlation between Harvia and Herantis is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Harvia Oyj and Herantis Pharma Oyj in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Herantis Pharma Oyj and Harvia Oyj is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Harvia Oyj are associated (or correlated) with Herantis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Herantis Pharma Oyj has no effect on the direction of Harvia Oyj i.e., Harvia Oyj and Herantis Pharma go up and down completely randomly.

Pair Corralation between Harvia Oyj and Herantis Pharma

Assuming the 90 days trading horizon Harvia Oyj is expected to under-perform the Herantis Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Harvia Oyj is 1.7 times less risky than Herantis Pharma. The stock trades about -0.02 of its potential returns per unit of risk. The Herantis Pharma Oyj is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  143.00  in Herantis Pharma Oyj on October 25, 2024 and sell it today you would earn a total of  18.00  from holding Herantis Pharma Oyj or generate 12.59% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Harvia Oyj  vs.  Herantis Pharma Oyj

Harvia Oyj

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Harvia Oyj has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Harvia Oyj is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Herantis Pharma Oyj

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Herantis Pharma Oyj are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak technical indicators, Herantis Pharma demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Harvia Oyj and Herantis Pharma

The main advantage of trading using opposite Harvia Oyj and Herantis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Harvia Oyj position performs unexpectedly, Herantis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Herantis Pharma will offset losses from the drop in Herantis Pharma's long position.

The idea behind Harvia Oyj and Herantis Pharma Oyj pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.